Skip to main content
Premium Trial:

Request an Annual Quote

This Week in Nucleic Acids Research: Aug 29, 2018

A University of Pennsylvania-led team introduces software for teasing out the effects of non-coding variants found in genome-wide association studies. The approach — called "Inferring the molecular mechanisms of noncoding genetic variants," or INFERNO — quantifies tissue-specific enhancers and other regulatory features using statistical methods informed by transcription factor, expression quantitative trait locus, and other functional genomic datasets, the researchers explain. When they applied INFERNO to schizophrenia and inflammatory bowel disease GWAS data, for example, the investigators identified causal variants at brain and immune enhancers, respectively.

University of Groningen and University of Lausanne researchers present an annotated genome sequence for a strain of Streptococcus pneumoniae called D39 that's commonly used in pneumococcal research. The team did de novo genome sequencing on a D39 isolate from serotype 2, putting together a genome assembly based on long reads that were polished with short read data. A deep annotation of the S. pneumoniae genome and transcriptome led to new genes, more than 1,000 transcription start sites, and nearly 750 termination sites, the authors report, noting that they developed a genome browser called PneumoBrowse to delve into the genetic and regulatory features of the opportunistic pathogen.

For a related study, members of the same Groningen and Lausanne team dig into the transcriptional features found in S. pneumoniae grown in infection-relevant settings. For that analysis, the researchers used RNA sequence data for S. pneumoniae isolates grown in nearly two dozen growth conditions. "The data demonstrated a high level of dynamic expression and, strikingly, all annotated pneumococcal genomic features were expressed in at least one of the studied conditions," the authors report. In addition to exploring co-expression and regulation of the S. pneumoniae genes, they brought the expression data together with an interactive tool dubbed PneumoExpress.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.